Tarsus Pharmaceuticals Inc. (TARS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Tarsus Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$72.05
+1.82% today
Market cap
$3.5B
Overall quality
—
Kronos AI 30-day
+3.8%
5 of 8 simulated paths end higher
Tarsus Pharmaceuticals Inc. (TARS) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $3.5B. It trades at $72.05, up 1.82% today. 9 analysts' average target of $100.88 implies +40.0% from today's price. Kronos AI's 30-day forecast is +3.8% (5 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $100.88 |
| Low – high | $84.00 – $116.00 |
| Analysts | 9 |
| Upside to average | +40.0% |
Kronos AI 30-day forecast
| Expected close | $73.43 (+3.8%) |
| Likely range | −4.1% … +10.0% |
| As of | 2026-10-27 |
5 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.